Grape King Bio (1707.TW)

Grape King Bio stock price today, ATLAS forecast and fair value

Healthcare · Drug Manufacturers - Specialty & Generic · Taiwan Stock Exchange · Taiwan

NT$83.80▼ -1.64%

Prices as of Oct 27, 2026 · TWD

ATLAS fair value

NT$186.46

Below fair value · 55% discount

Chance of rising in 1 month

55%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Grape King Bio in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Grape King Bio

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Grape King Bio's fair value at about NT$186.46 per share (reasonable range: NT$155.96 to NT$263.54). At NT$83.80, the stock trades 55% below it.

It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Grape King Bio a 55% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between NT$82.04 and NT$86.44; in 9 out of 10, between NT$78.32 and NT$90.54. Estimated annual volatility is 15%.

Price, last 12 months (weekly close)

Grape King Bio (1707.TW) — Price, last 12 months (weekly close)Oct 23, 2025: NT$124.50. Oct 27, 2026: NT$83.80. ▼NT$130.00NT$83.80Oct 23, 2025Oct 27, 2026

Key numbers

Market cap
NT$13.0B
Market cap (USD)
$402M
P/E ratio
11.1
Dividend yield
7.01%
52-week high
NT$130.00
52-week low
NT$83.50
Revenue (12 months)
NT$10.1B
Gross margin
73.5%
Operating margin
17.1%
Net margin
11.3%
Beta
0.23

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Grape King Bio sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks 1707.TW has traded between NT$83.50 and NT$130.00. Today it is 35.5% below that high and 0% above its low.

On the business: net margin is 11.3%; it trades at 11.1 times earnings.

Its beta is 0.23: it tends to move less than the market.

About the company

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally.

Want to see everything about Grape King Bio?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Grape King Bio (1707.TW) fair value?

About NT$186.46 per share according to ATLAS (reasonable range: NT$155.96 to NT$263.54). With the stock at NT$83.80, it is 55% below it.

What is the chance 1707.TW goes up next month?

55%: close to a coin flip. In half of the simulated outcomes, 1707.TW ends the month between NT$82.04 and NT$86.44.

How big is Grape King Bio and what is its P/E ratio?

Grape King Bio's market capitalization is NT$13.0B. Its price-to-earnings (P/E) ratio is 11.1: you pay NT$11.1 for each NT$1.00 of yearly earnings.

Does Grape King Bio pay a dividend?

Yes. 1707.TW's current dividend yield is 7.01% at today's price (NT$83.80).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy